2022 - Research.com Best Female Scientist Award
Her primary areas of study are Internal medicine, Cancer, Gastroenterology, Cancer research and Immunology. Her studies in Internal medicine integrate themes in fields like Surgery, Oncology and Pathology. Her Oncology research focuses on Temsirolimus and how it connects with Sirolimus.
Razelle Kurzrock interconnects Malignancy, Carcinoma, Personalized medicine, Biomarker and Lung cancer in the investigation of issues within Cancer. Her Gastroenterology study combines topics in areas such as Pharmacokinetics, Survival rate, Interferon alfa, Lymphoma and Leukemia. Her Cancer research research also works with subjects such as
Her scientific interests lie mostly in Internal medicine, Oncology, Cancer, Cancer research and Gastroenterology. Her Internal medicine study combines topics from a wide range of disciplines, such as Surgery and Pharmacology. The Oncology study combines topics in areas such as Bevacizumab, Breast cancer, Melanoma and Immunotherapy.
Her Cancer study integrates concerns from other disciplines, such as Phases of clinical research, Lung cancer, Pathology and Bioinformatics. Her work deals with themes such as Mutation, Chronic myelogenous leukemia, Protein kinase B and PI3K/AKT/mTOR pathway, which intersect with Cancer research. Her study in Gastroenterology is interdisciplinary in nature, drawing from both Toxicity, Neutropenia, Chemotherapy, Immunology and Nausea.
The scientist’s investigation covers issues in Internal medicine, Oncology, Cancer research, Cancer and Immunotherapy. Her study connects Gastroenterology and Internal medicine. Her research in Oncology focuses on subjects like Targeted therapy, which are connected to Combination therapy.
Her work carried out in the field of Cancer research brings together such families of science as Immune checkpoint, Cell, Gene and Immune checkpoint inhibitors. Her research investigates the connection between Cancer and topics such as Biopsy that intersect with issues in Standardized uptake value. Razelle Kurzrock has included themes like Nivolumab, Ipilimumab and Phases of clinical research in her Clinical endpoint study.
Razelle Kurzrock spends much of her time researching Internal medicine, Oncology, Cancer research, Cancer and Immunotherapy. Her studies deal with areas such as Gastroenterology and Precision medicine as well as Internal medicine. Her Oncology research includes themes of Targeted therapy, Breast cancer, Colorectal cancer and Phases of clinical research.
Her research in Cancer research intersects with topics in Immune checkpoint, Biomarker and Gene, GNAS complex locus. The study incorporates disciplines such as Sarcoma and Hazard ratio in addition to Cancer. She has researched Immunotherapy in several fields, including Mutation, Blockade, Melanoma and Microsatellite instability.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The biology of chronic myeloid leukemia
Stefan Faderl;Moshe Talpaz;Zeev Estrov;Susan O'Brien.
The New England Journal of Medicine (1999)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel;Razelle Kurzrock.
Molecular Cancer Therapeutics (2015)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers.
Aaron M. Goodman;Shumei Kato;Lyudmila Bazhenova;Sandip P. Patel.
Molecular Cancer Therapeutics (2017)
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Navneet Dhillon;Bharat B. Aggarwal;Robert A. Newman;Robert A. Wolff.
Clinical Cancer Research (2008)
The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias
Razelle Kurzrock;Jordan U. Gutterman;Moshe Talpaz.
The New England Journal of Medicine (1988)
Epstein-Barr Virus and Cancer
Matthew P. Thompson;Razelle Kurzrock.
Clinical Cancer Research (2004)
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
Gerald S Falchook;Georgina V Long;Georgina V Long;Razelle Kurzrock;Kevin B Kim.
The Lancet (2012)
Autophagy as a target for anticancer therapy
Filip Janku;David J. McConkey;David S. Hong;Razelle Kurzrock.
Nature Reviews Clinical Oncology (2011)
Clinical toxicity of interferons in cancer patients: a review.
Jorge R. Quesada;Moshe Talpaz;Adan Rios;Razelle Kurzrock.
Journal of Clinical Oncology (1986)
Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate
Shumei Kato;Aaron Michael Goodman;Vighnesh Walavalkar;Donald A. Barkauskas.
Clinical Cancer Research (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: